Intravitreal bevacizumab for posterior capsule neovascularization
SJO-Saudi Journal of Ophthalmology. 2010; 24 (2): 63-65
em En
| IMEMR
| ID: emr-98430
Biblioteca responsável:
EMRO
ABSTRACT
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab [Avastin] followed by neodymiumYAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization
Buscar no Google
Índice:
IMEMR
Assunto principal:
Resultado do Tratamento
/
Inibidores da Angiogênese
/
Fator A de Crescimento do Endotélio Vascular
/
Anticorpos Monoclonais
Tipo de estudo:
Case_reports
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Saudi J. Ophthalmol.
Ano de publicação:
2010